Artwork

Content provided by The Immunology Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Immunology Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Ep. 79: “ILC2s, the Microbiome, and Fibroblasts” Featuring Dr. Kellen Cavagnero

1:09:17
 
Share
 

Manage episode 422009581 series 2895470
Content provided by The Immunology Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Immunology Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Guest:

Dr. Kellen Cavagnero is a Postdoctoral Fellow at the University of California, San Diego. His PhD work focused on how fibroblasts — a cell type thought to be immunologically inert — contribute to chronic inflammatory conditions and defense against pathogens. He talks about staph infections, antimicrobial resistance, and the types and roles of fibroblasts. He also discusses his work in science communication, including his podcast, Inflammatory Content.

Featured Products and Resources:

The Immunology Science Round Up

Malaria Immunity – Scientists leveraged a human malaria infection study to investigate functional correlates of immunity.

CAR T Therapy for HIV – Anti-HIV-1 CAR-T cells armed with endogenic broadly neutralizing antibodies resulted in significant suppression of viral rebound in HIV patients.

Immunogenic Cell Death – Researchers generated a small-molecule proteolysis-targeting chimera that selectively degraded human and murine RIPK1.

Origins of Autoimmunity – NUDCD3 is required for healthy T and B cell development in humans.

Image courtesy of Dr. Kellen Cavagnero

Subscribe to our newsletter!

Never miss updates about new episodes.

Subscribe
  continue reading

133 episodes

Artwork
iconShare
 
Manage episode 422009581 series 2895470
Content provided by The Immunology Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Immunology Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Guest:

Dr. Kellen Cavagnero is a Postdoctoral Fellow at the University of California, San Diego. His PhD work focused on how fibroblasts — a cell type thought to be immunologically inert — contribute to chronic inflammatory conditions and defense against pathogens. He talks about staph infections, antimicrobial resistance, and the types and roles of fibroblasts. He also discusses his work in science communication, including his podcast, Inflammatory Content.

Featured Products and Resources:

The Immunology Science Round Up

Malaria Immunity – Scientists leveraged a human malaria infection study to investigate functional correlates of immunity.

CAR T Therapy for HIV – Anti-HIV-1 CAR-T cells armed with endogenic broadly neutralizing antibodies resulted in significant suppression of viral rebound in HIV patients.

Immunogenic Cell Death – Researchers generated a small-molecule proteolysis-targeting chimera that selectively degraded human and murine RIPK1.

Origins of Autoimmunity – NUDCD3 is required for healthy T and B cell development in humans.

Image courtesy of Dr. Kellen Cavagnero

Subscribe to our newsletter!

Never miss updates about new episodes.

Subscribe
  continue reading

133 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play